LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $17,915,000 | +54.6% | 9,820,000 | +40.3% | 0.00% | +50.0% |
| Q2 2017 | $11,585,000 | +211.0% | 7,000,000 | +180.0% | 0.00% | +100.0% |
| Q1 2017 | $3,725,000 | -1.3% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,775,000 | -11.9% | 2,500,000 | -13.6% | 0.00% | 0.0% |
| Q1 2016 | $4,286,000 | +2.9% | 2,895,000 | +8.3% | 0.00% | 0.0% |
| Q4 2015 | $4,165,000 | -9.4% | 2,673,000 | -23.6% | 0.00% | 0.0% |
| Q3 2015 | $4,597,000 | – | 3,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mint Tower Capital Management B.V. | 12,000,000 | $19,882,000 | 4.94% |
| CQS Cayman LP | 25,000,000 | $41,458,000 | 2.86% |
| BASSO CAPITAL MANAGEMENT, L.P. | 12,245,000 | $20,273,000 | 2.64% |
| TFG Asset Management GP Ltd | 6,100,000 | $10,116,000 | 1.50% |
| CSS LLC/IL | 11,490,000 | $19,090,000 | 0.93% |
| ANGELO GORDON & CO., L.P. | 8,500,000 | $14,068,000 | 0.69% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 27,500,000 | $45,566,000 | 0.68% |
| Verition Fund Management LLC | 3,200,000 | $5,312,000 | 0.52% |
| SHENKMAN CAPITAL MANAGEMENT INC | 2,932,000 | $4,867,000 | 0.44% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $7,962,000 | 0.30% |